AIDS

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	60
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	56
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	48
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	48
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	48
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	37
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	37
Real world use of dolutegravir two drug regimens	36
Cerebral toxoplasmosis in the twenty-first century	35
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	31
Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum	30
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research	29
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	29
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	26
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	26
Applying rigorous real-world evidence methodology in HIV medicine: is more evidence needed with long-acting cabotegravir/rilpivirine?	25
Trends in population HIV viral suppression: a longitudinal analysis	25
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	24
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	24
Life expectancy of people with HIV on antiretroviral therapy in Spain	23
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	23
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	23
Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort	22
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	22
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	22

Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	21
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	21
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	21
Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	21
Parallel declines in antiretroviral therapy adherence by dried blood spot and electronic monitoring in Cape Town, South Africa	21
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	20
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	20
Association between low bone mass and fracture prevalence among children living with HIV in Africa	20
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	20
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	20
Fatty liver disease in children living with HIV: a ghostly iceberg	19
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	19
Not all costs are the same: understanding costs of opioid agonist treatment around the world	19
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	19
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	19
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trial	19
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	19
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	19
HIV and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex in rural South Africa	19
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	18
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	17
Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV	17
Social cognition in people with HIV: a neglected cognitive domain?	17
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	17
Increased risk of false-positive HIV ELISA results after COVID-19	17
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	17
Is baseline genotyping still necessary before initiating long-acting cabotegravir and rilpivirine?	17
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	17
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	17
Lower working memory and processing speed among children and youth exposed to HIV	17
Age-associated dementia among older people aging with HIV in the United States: a modeling study	17
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	16
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	16
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	16
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	16
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	16
Sexually transmitted infections in the preexposure prophylaxis era	16
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	16
HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015–2022	15
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	15
Sustained viral suppression among people with HIV in the era of Undetectable = Untransmittable (U = U) in Australia	15
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	15
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	15
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	15
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	14
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	14
A note of thanks to our reviewers	14
HIV and race are independently associated with endothelial dysfunction	14
Prevalence and resistance patterns of Mycoplasma genitalium infection in people with HIV: a systematic review and meta-analysis	14
Altered mitochondrial mass and fatty acid uptake by natural killer cells in HIV-exposed uninfected children at 6 years of age	14

Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	14
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	14
The relationship between HIV and reading performance for children in Tanzania	14
Endoplasmic reticulum stress-induced goblet cell apoptosis might contribute to intestinal barrier damage in asymptomatic people with HIV	13
Bone turnover marker trajectories in postpartum women with HIV compared to women without HIV	13
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	13
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	13
High body mass and depression accelerate physical decline in people with HIV: can exercise reverse the clock?	13
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers	13
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	13
Validity of competing algorithms to identify people with HIV in Medicaid administrative claims: a statewide analysis	13
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	13
Children who are HIV-exposed and uninfected: evidence for action	13
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	13
Poverty and protection: the relationship between multidimensional poverty, social protection interventions, and HIV viral load	13
Predictors of intact HIV DNA levels among children in Kenya	13
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	13
Cabotegravir/rilpivirine in pregnancy: early insights from clinical practice	12
Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort	12
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	12
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	12
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	12
Impaired kidney function in People with HIV compared to People without HIV	12
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	12
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	12
The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multisite cohort study	12
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	12
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	12
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	11
Global health solidarity in the HIV and hypertension disease response	11
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	11
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	11
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	11
Cervical cancer screening in women with HIV: an audit of clinical care	11
Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV	11
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	11
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	11
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	11
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	11
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	11
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	11
No cause for complacency regarding health of children who are HIV-exposed but uninfected	11
Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy	11
Auditory and cognitive function in older adults living with and without HIV	11
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	11
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among MSM in China	11
New tuberculosis vaccines for people with HIV	10
Longitudinal assessment of inflammatory biomarkers among youth with perinatal HIV infection and HIV exposure	10
Quantifying brain-age gap in people with HIV on antiretroviral therapy using plasma neurofilament light chain	10
HIV-positive Ukrainian refugees in the Czech Republic	10
The Potential Impact of Reduced Donor Funding for HIV Programs on Malawi's Disease Burden	10
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	10
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	10
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	10
Fungal diseases are not in the radar of main international HIV conferences	10
One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysis	10
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	10
Associations between HIV serostatus and coronary artery plaque volume progression	10
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	10
The incidence and dynamic risk factors of chronic kidney disease among people with HIV	10
Racial disparities in cancer risk among MSM with HIV in the United States	10
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	10
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	10
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	10
Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis	10
The past that haunts: lessons from missed resistance history	10
Housing is harm reduction	10
Risk and predictors of penile cancer in US Veterans with HIV	10
HIV-1 gp120 exposure associates with mitochondrial and pyruvate kinase M remodeling in cardiomyocytes	10
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	10
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	10
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption	10
Factors associated with survival in patients with lymphoma and HIV	9
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	9
Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations	9
Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes	9
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	9
Letter to the editor regarding “Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy”	9
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	9
Food insecurity likely contributes to frailty in people with HIV	9

Altered bile acid metabolism in people with HIV correlates with systemic and intestinal inflammation	9
HIV and mpox: a rapid review	9
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	9
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV	9
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	9
Deciphering HIV vaccine-induced antibody response according to ethnicity	9
Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohort	9
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	9
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	9
Carotid inflammation on FDG-PET is associated with lower cognitive performance in people with treated HIV infection	9
The application of new metrics for understanding trends in undiagnosed HIV among key populations	9
Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy	9
Addressing the burden of HIV-associated chronic lung disease in West Africa	9
Exposure to size-specific particulate matter accelerates DNA methylation aging in people living with HIV	9
Self-injurious unnatural death among Veterans with HIV	9
The HIV-2 proviral landscape is dominated by defective proviruses	9
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	8
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	8
Persistent immunological repercussions of late antiretroviral initiation in children with HIV	8
Dolutegravir-induced neural tube defects in mice are folate responsive	8
Initial antiretroviral therapy regimen and risk of heart failure	8
Adherence, acceptability, preference and safety of placebo Long-Acting Pre-exposure Prophylaxis (LA-PrEP) injections and implants for HIV-Prevention in South African Men	8
Contribution of HIV transmission bursts to future HIV infections	8
Transplantation of kidneys from donors with HIV: are we there yet?	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	8
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	8
Incidence of high blood pressure among Kenyan adults with HIV	8
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	8
On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: why ending the HIV epidemic must address these factors for success	8
The US President's Emergency Plan for AIDS Relief-funded service integration protected children from tuberculosis	8
Erratum: Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV	8
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	8
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Improved screening for pulmonary Kaposi sarcoma in a low-resource setting	8
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	8
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Time-dependent mortality effects of dynamic antiretroviral therapy regimens	8
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	8
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	7
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	7
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	7
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	7
Left behind? A longitudinal analysis of need for preexposure prophylaxis services among middle-aged and older adults in South Africa	7
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	7
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	7
Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort	7
Maternal and pregnancy outcomes in women offered daily oral preexposure prophylaxis during pregnancy and postpartum	7
Human herpes virus 8-related illness: still with us	7
Impaired CD4+ T-cell and CD4+/CD8+ ratio recovery among people with HIV on antiretroviral therapy	7
A systematic review of models used to estimate undiagnosed HIV prevalence in high-income low-prevalence countries and territories	7
Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana	7
Community PrEP delivery preferences among pregnant and breastfeeding women using oral PrEP in South Africa and Kenya	7
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	7
Differential genome-wide associated variants and enriched pathways of ECG parameters among people with versus without HIV	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
AIDS: changes in leadership	7
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	7
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000–2019	7
HIV prevalence in transgender women and cisgender men who have sex with men in sub-Saharan Africa	7
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	7
Association between HIV and cancer risk	7
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	7
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	7
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	7
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	7
Care interruptions and mortality among adults in Europe and North America	7
Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV	6
Estimated cost-effectiveness of point-of-care testing in community pharmacies vs. self-testing and standard laboratory testing for HIV	6
Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation	6
Antiretroviral utilization and adherence before vs. after expansion of a provincial drug insurance policy	6
Cancer risk among HIV-exposed uninfected children in the United States	6
Inference of HIV-1 transmission direction between men who have sex with men (MSM) and their wives in China	6
HIV–sex interaction effect on risk of hepatitis C–related cirrhosis, decompensation, and hepatocellular carcinoma	6
Leveraging HIV/AIDS infrastructure for sustainable healthcare services in sub-Saharan Africa	6
Development of Frail RISC-HIV: a Risk Score for Predicting Frailty Risk in the Short-term for Care of People with HIV	6
Target trials of preconception switch from nevirapine or efavirenz-based antiretroviral therapy to dolutegravir-based antiretroviral therapy on adverse birth and maternal outcomes	6
Use of doravirine-based regimens in clinical practice in Europe	6
Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil	6
Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?	6
Medical comorbidities and lower myelin content are associated with poor cognition in young adults with perinatally acquired HIV	6
Modeling the potential impact of viral load monitoring on vertical transmission of HIV in Kenya	6